Aulos Bioscience

Developer of antibody therapeutic solutions for the treatment of cancer. The company is involved in the development of IL-2 targeting antibodies that mainly known as Interleukin-2 (IL‑2) cytokine secreted by activated T-cells provides treatment solutions for solid tumors. It has a CD25 binding site that binds antibodies to the respective cancer cells.